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I. Introduction 
The circulating plasma triacylglycerol, which is 
transported mainly in the chylomicrons and very low 
density lipoproteins (VLDL), is hydrolyzed prior to 
the uptake in the extrahepatic tissues by lipoprotein 
lipase (LPL. EC 3.1.1.3). LPL is present in myo- 
cardium, adipose tissue and skeletal muscle [l-3] 
and has been suggested to be bound to the sulphated 
glycosanlino~ycans on the luminal surface of the 
vascultlr endothelium in these tissues 131. There is 
direct evidence that LPL is the rate limiting step in 
the removal of plasma triacylglycerol /4]. 
The molecular properties of LPL are still poorly 
understood. This is probably due to the fact that 
until recently no methods were available for the 
purification of relative large quantities of homoge- 
nous LPL. A rich source of LPL is bovine milk [S] . 
The enzymatic properties (i.e.,inhibition by protamine 
and by high ionic strength, activation by apolipo- 
protein C-II) of both bovine milk LPL and human 
postheparin plasma LPL are identical [5,6], and they 
show inijnurloiogical cross-reactivity /7] and have 
very simiiar amino acid composition [8-lo]. We 
therefore have used the bovine milk LPL as a mode1 
to study the enzymatic properties of LPL in general. 
For full activity LPL requires a co-factor, apolipo- 
protein C-II [6], which is a component of both 
chylomicron and VLDL surface film [ 11 ,131. LPL 1s 
stercospecific in the presence of serum activator: it 
preferentially cleaves the ester bond between the acyl 
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group and the sn-l carbon of the glycerol backbone 
of triacylglycerol [13,14]_ We wanted to study, 
whether the apoprotem activator affects this stereo- 
specificity, or whether the stereospecificity of LPL is 
an intrinsic property of the active site of the enzyme 
molecule. 
2. Materials and methods 
2.1 . Lipoprotein lipase 
LPL was purified to ~lomogeneity from bovine 
milk using chromatography on agarose beads with 
covalently-linked heparin [IS]. The purified enzyme 
was stored in 20 mM Tris-HCI buffer (pH 7.4) con- 
taining 50% (v/v) glycerol and 2.0 M NaCl at 20°C 
without any loss of activity. 
2.2. Apolipoproteirz C-II 
ApoC-II was purified from human plasma VLDL 
as in [16,17]. 
The labefled enantiomeric triacylglycerol analogs 
were as in [ 13,141. Egg lecithin w3s purified as in 
[Id. 
2.4. Enz_vme incubations 
The substrate hpids were mixed in chloroform and 
dried under nitrogen. After the addition of 1.25 ml 
0.2 M Tris-HCl buffer (pH 8.4), the mixture was 
mixed on vortex mixer at maximal speed for 5 min. 
The resulting emulsion gave identical reaction rates 
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as substrate for LPL with an emulsion prepared by 
sonication. The final incubation mixture contained 
in 2.5 ml total vol. 0.1 M Tris-HCl buffer (pH 8.4), 
the following compssnents: 50 nmol 1-0-[9,10-3H2]- 
octadecyl-2,3-dioctadecenoyl-sn-glycerol, spect. act. 
0.11 mCi/mmol, 50 nmol 30-[1-‘4C]octadecyl- 
1,2-dioctadecenoyl-sn-glycerol, spect. act. 0.05 
mCi/mmol, 0.38 mmol NaCl, 2.5 mg bovine serum 
albumin and 10.9 1.18 (1.24 nmol) apoC-II, when 
indicated. At the times illustrated in the figures 
aliquots were taken from the mixture incubated with 
LPL in a water bath at +35”C and extracted as in 
[ 191 . The lipids were separated on silica gel-coated 
plates (Merck) developed with hexan/diethylether/ 
acetic acid (70/30/2). The separated lipids were 
measured for 3H- and 14C-radioactivity as in [ 131. 
3. Results and discussion 
3.1. Stereospecificity in the presence of apoC-II 
The stereospecificity reported [ 13,141 for lipo- 
protein lipase was confirmed in our experiments 
using purified LPL and purified activator, apoC-II, 
fig. 1. The substrate containing the alkyl group in 
the srz-I position was hydrolyzed much slower than 
the substrate with the alkyl group in the ~2-3 posi- 
tion. As the l(3)-alkyl-3(l)-acylglycerol did not 
exceed >lO% of the total alkylacylglycerol formed, 
the alkylacylglycerol is expressed as total. Thus 
equal product formation was achieved both by puri- 
fied components and crude preparations (fig.1 and 
P31). 
3.2. Stereospecificity in the absence of apoC-II 
The above experiments were performed in the 
presence of apoC-II, a small molecular weight peptide 
required for full activity of the enzyme. It has been 
shown that there is a protein-protein interaction 
between apoC-II and LPL, reversible at high ionic 
strength [20] . There is evidence for the formation of 
1: 1 stoichiometric complex [2 1,221. Thus apoC-II 
could change the conformation of LPL so as to 
favor the hydrolysis of the ester bond between the 
acyl group and the sn-I carbon of the glycerol back- 
bone. ApoC-II is known to bind lipids [24]. One 
possible mechanism for the activation of LPL by 
apoC-II could be the binding of the substrate triacyl- 
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Fig.1. Hydrolysis of egg-lecithin stabilized enantiomeric 
l(2)-alkyl-2,3(1,2)-diacylglycerols by lipoprotein lipase in the 
presence of apoC-II. Detailed description of the assay mixture 
is in section 2. The reaction was started by the addition of 
1.1 ~.cg (0.02 nmol) purified LPL. At the indicated times 
450 ~1 aliquots were withdrawn and analyzed for lipid radio- 
activity. (o,*) Alkyldiacylglycerol; (a,~) alkylacylglycerol: 
(o,m) alkylglycerol. Open symbols represent lipids with the 
alkyl group in the sn-I position and closed symbols those 
with the alkyl group in the 92-3 position. 
glycerol by apoC-II, which then guides the triacyl- 
glycerol properly into the active site of the enzyme. 
As this could have an effect on the stereospecificity 
of the enzyme, it was of interest to study the stereo- 
specificity of LPL also in the absence of apoC-II. As 
shown in fig.2, approximately identical hydrolytic 
pattern was obtained by LPL in the absence of 
apoC-II as in its presence. Thus the stereospecificity 
of LPL seems to be an intrinsic property of the 
enzyme molecule per se, which is not affected by 
apoC-II activator. Accordingly, apoC-II may be 
needed only for the enhancement of the catalytic 
rate constant of LPL. This is further supported by 
the observation that apoC-II does not affect the 
surface pressure optimum of LPL, when monolayers 
of trioctanoylglycerol at an air/water interface were 
used as a substrate [23] . 
It can be concluded that purified LPL exhibits 
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Fig.2. Hydrolysis of egg-lecithin stabilized enantiomeric 
l(3)-alkyl-2,3(1,2)-diacylglycerols by lipoprotein lipase in 
the absence of apoC-II. The assay conditions were essentially 
identical to those in fig.1, but the reaction mixture did not 
contain apolipoprotein C-II and the amount of LPL used was 
5.5 ~.rg (0.1 nmol). The symbols used are as in fig.1. 
stereospecificity unaffected by the apoprotein 
activator. As the enzyme also hydrolyzes l(3)-alkyl- 
3(l)-acylglycerols with equal rates [ 131, it is 
probable that the enzyme molecule specifically inter- 
acts with the carbonyl group in the 92-2 position of 
the glycerol backbone, which then causes the sn-1 
acyl group to be cleaved preferentially. Studies to 
confirm this binding site in LPL are at present in 
progress. 
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